Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 701–800 of 978
Chen, Z., Cai, L., Qin, Q., Li, X., Lu, S., Sun, L., Zhang, Y., Qi, L., & Zhou, T. (2024) · Journal of Physical Activity and Health · doi:10.1123/jpah.2023-0576 · Cited by 6
Machado‐Duque, M. E., García-Ospina, D. A., Emura-Vélez, M. H., Gaviria‐Mendoza, A., & Machado‐Alba, J. E. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211007015 · Cited by 5
Williams, B. A., Brady, J. P., Voyce, S. J., Kumar, N., Paprocki, Y., & RAJPURA, J. R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14686 · Cited by 5
“Concurrently, following an extended period of improving CV risk factor control, multiple recent studies have shown risk factor control in T2D to be worsening or stagnating.(3,24,27,28,35,36) For instance, in a recent”
BackgroundResultChehal, P. K., Uppal, T. S., Ng, B. P., Alva, M. L., & Ali, M. K. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07842-5 · Cited by 5
“The ED may ultimately serve as the primary source of care for these patients.(22) For others, the benefits of ambulatory care may be offset by other factors like mistrust or discrimination resulting in persistent complications.”
BackgroundSelf-citationMei, Y., Yang, X., Li, Y., Zhang, X., Gui, J., Wang, Y., Chen, W., Chen, M., Liu, C., & Zhang, L. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s398438 · Cited by 5
“0% from 2007–2010.(10) Increasing the level of glycemic control in patients with T2DM is an important medical goal.”
BackgroundThe trend of achieving ABC goals in patients with type 2 diabetes between 2010-2014 and 2015–2019
Tavakoli, M., Seifouri, S., Seifouri, K., Reyhan, S. K., Rajab, A., Esteghamati, A., Nakhjavani, M., & Rabizadeh, S. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100498 · Cited by 5
Tsai, H.-C., Hsu, P.-S., Pan, L.-F., Hung, C.-L., Yang, D., Hung, K.-C., & Liao, C. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03406-5 · Cited by 6
Stressing the Importance of Diabetes Distress: a Comment on Baek et al.
Beverly, E. A. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-014-9602-2 · Cited by 7
de la Pisa, B. P., Calzada, C. M., Sánchez, C. C., Jiménez, J. M. C., Gamaza, M. F., & Martínez, M. I. M. (2014) · Atención Primaria · doi:10.1016/j.aprim.2014.05.004 · Cited by 6
Grant, R. W., Ashburner, J. M., Jernigan, M. C., Chang, J. P., Borowsky, L. H., Chang, Y., & Atlas, S. J. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3152-y · Cited by 5
Salem, M., Al-Ali, A., & Bashwar, Z. (2015) · BMJ Quality Improvement Reports · doi:10.1136/bmjquality.u207778.w3190 · Cited by 5
“Patients with type 2 diabetes have an increased prevalence of lipid abnormalities, contributing to their high risk of CVD.[3] Multiple clinical trials have demonstrated the signi?cant effects of pharmacological (primarily statin) therapy on CVD outcomes in individual subjects with CHD and for primary CVD prevention.”
BackgroundRaz, I., Cefalu, W. T., ILKOVA, H. M., & Prato, S. D. (2016) · Diabetes Care · doi:10.2337/dcs15-3030 · Cited by 5
Genetic Susceptibility to Oxidative Stress and Cardiovascular Disease
Huggins, G. S. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.042 · Cited by 5
“…Inhibitors (statins) and blood pressure lowering agents are showing signs of success as rates of coronary heart disease are on the decline (Ali et al., 2013); however, a substantial amount of residual risk remains suggesting that additional prevention strategies are needed particularly in…”
BackgroundBlackstone, R. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-39409-1_5 · Cited by 8
Marker, D. A., Mardon, R., Jenkins, F., Campione, J. R., Nooney, J. G., Li, J., Saydeh, S., Zhang, X., Shrestha, S. S., & Rolka, D. B. (2018) · Statistics in Medicine · doi:10.1002/sim.7848 · Cited by 5
Smetana, G. W., Nathan, D. M., Dugdale, D. C., & Burns, R. B. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0946 · Cited by 8
A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
Kang, W. Y., Lee, H. W., Gwon, M., Cho, S., Shim, W.-S., Lee, K., Yang, D. H., Seong, S. J., & Yoon, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s248205 · Cited by 5
Evaluation of a Community-Based Cardiovascular Prevention Program in Patients With Type 2 Diabetes
Finn, Y., Gorecka, M. M., Flaherty, G. T., Dunne, F., O’Brien, T., Crowley, J. J., Wood, D., Connolly, S. B., Jones, J. L., & Gibson, I. (2020) · American Journal of Health Promotion · doi:10.1177/0890117120931711 · Cited by 5
“In a US survey at least a third of approximately 100 000 persons with diabetes did not meet individual targets for glycemia, blood pressure, and cholesterol and only a small percentage achieved all 3 targets.(7) Results from the EUROASPIRE V study (2016-2017) reported risk factor management in persons with CVD.”
BackgroundSUKKARIEH-HARATY, O. A., Egede, L. E., & Bassil, M. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109818 · Cited by 5
McRae, M., & Wang, C. C. L. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.012 · Cited by 8
Teshome, T., Sorato, M. M., Ayele, A., Hailu, T., Tunje, A., & Bussa, Z. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.355 · Cited by 7
CHANDRAN, S. R., Tan, H. C., Chen, Q., Lee, P. C., Gardner, D. S.-L., Chin, Y. A., Lam, A. Y. R., Teh, M. M., & Bee, Y. M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231157387 · Cited by 5
Chen, T., Wang, Z., Xie, J., Xiao, S., & Liu, N. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.04.012 · Cited by 5
Ma, J., Lu, J., Shen, P., Zhao, X., & Zhu, H. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2222847 · Cited by 8
“…t2DM. however, according to data from the United states National health and Nutrition examination survey and the Behavioral Risk Factor surveillance system, in the past decade, blood glucose, blood pressure, and serum lipid controls could not be achieved in 33.4%–48.7% of patients with t2DM [8].”
MethodInfluentialInternal Medicine Resident Training and Provision of Diabetes Quality of Care Indicators
Devkota, B. P., Ansstas, M., Scherrer, J. F., Salas, J., & Budhathoki, C. B. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.10.001 · Cited by 5
Paes, V. M., Charalampopoulos, D., Khanolkar, A. R., Taylor-Robinson, D. C., Viner, R., Edge, J., Stephenson, T. J., & Amin, R. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0146-8 · Cited by 5
“The mean HbA1c level in the intensively treated group participating for more than 20 years ago in the DCCT was lower than the HbA1c levels in most patients today [59, 60].”
BackgroundLeśniak, W., Bała, M. M., Płaczkiewicz‐Jankowska, E., Topór‐Mądry, R., Jankowski, M., Sieradzki, J., & Banasiak, W. (2015) · Cardiology Journal · doi:10.5603/cj.a2014.0067 · Cited by 5
Yokoyama, H., Yamamoto, T., Tanaka, M., Kudo, C., Hidaka, K.-I., Kuribayashi, N., & Minabe, M. (2018) · Diabetology International · doi:10.1007/s13340-018-0388-5 · Cited by 7
Baranwal, J. K., Maskey, R., Chaudhari, R. K., & Sherchand, O. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s262643 · Cited by 6
Bronstein, J. M., Huang, L., Shelley, J. P., Levitan, E. B., Presley, C. A., Agne, A. A., Mondesir, F. L., Riggs, K. R., Pisu, M., & Cherrington, A. L. (2022) · Primary Care Diabetes · doi:10.1016/j.pcd.2021.10.005 · Cited by 6
Trends in quality of primary care in the United States, 2007–2016
Saxena, A., Ramamoorthy, V., Rubens, M., McGranaghan, P., Veledar, E., & Nasir, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-06077-y · Cited by 5
Type 2 diabetes specialty clinic model for the accountable care organization era
Klingeman, H., Funnell, M. M., Jhand, A. S., Lathkar‐Pradhan, S., & Hodish, I. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.011 · Cited by 6
Improving cardiovascular risk in type 2 diabetes: time to get personal
Gelding, S. V. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw033 · Cited by 5
Glycemic control among Iranian people with type 2 diabetes: a systematic review and meta-analysis
Mohseni, M., Heidari‐Beni, M., & Kelishadi, R. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01102-2 · Cited by 5
Yogesh, M., Nagda, J., Babaria, D. L., & Misra, S. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1951_23 · Cited by 5
Majd, Z., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., & Abughosh, S. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102295 · Cited by 4
Malik, R. A., Anderson, J., Russo, G. T., Amani, M. E. A., Adaş, M., Alvarez, A., Lauand, F., Li, X., & Khunti, K. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16591 · Cited by 5
Wu, S., Wu, Y., Ning, Y., Peng, X., Zhao, H., Feng, J., Lin, L., Ruan, C., Chen, S., Tian, J., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.041223 · Cited by 4
Albasheer, O., Mahfouz, Alssum, A., Majrashi, M., Hamdi, A. A., Alhazmi, W. M., Hakami, B. H. O., Awaf, A., Hassan, R., Rajeh, N., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1763252 · Cited by 4
“However, several global studies, such as NHANES (USA) and the DAWN2 international study (involving 17 countries), have demonstrated universally low diabetes knowledge regardless of gender (24, 25).”
Six Impossible Things Before Breakfast: Examining Diabetes Self-Care
Weinger, K. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.2.146 · Cited by 4
Coughlin, S. S., Carbone, L. D., Heboyan, V., Williams, L. B., Hatzigeorgiou, C., Rangachari, P., & Leo, G. D. (2017) · mHealth · doi:10.21037/mhealth.2017.10.02 · Cited by 4
“Good glycemic control is associated with better patient outcomes, but almost half of patients with type 2 diabetes do not achieve glycemic control, or cholesterol or blood pressure control (3-5).”
BackgroundBerg, D. D., Kolkailah, A. A., Sarraju, A., Kerchberger, A. M., Eljalby, M., & McGuire, D. K. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01417-0 · Cited by 4
Combining Metabolic Surgery with Medications for Type 2 Diabetes: Is There a Benefit?
Sudlow, A. C., Pournaras, D. J., & le Roux, C. W. (2022) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_16_22 · Cited by 4
Zhang, X., Yip, T. C., Tse, Y., Hui, V. W., Li, G., Lin, H., Liang, L. Y., Lai, J. C., Lai, M. S., Cheung, J. T. K., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17428 · Cited by 4
Erbakan, A. N., Bahadır, M. A., Kaya, F. N., Güleç, B., Keskinler, M. V., Çelik, Ü. A., Faydalıel, Ö., Mesçi, B., & Oğuz, A. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i1.98322 · Cited by 4
James, S., Jabakhanji, S. B., Mehta, R., McCaffrey, J., Mairghani, M., Bhatia, D., James, O., Kehlenbrink, S., Boulle, P., Mehta, K. M., et al. (2025) · Conflict and Health · doi:10.1186/s13031-024-00631-3 · Cited by 4
Self-citationSawczyn, T., Stygar, D. M., Nabrdalik, K., Kukla, M., Skrzep-Poloczek, B., Wesołowski, B., Olszańska, E., Dulska, A., Gumprecht, J., Karcz, W. K., et al. (2019) · Peptides · doi:10.1016/j.peptides.2019.04.001 · Cited by 4
Targeting multiple domains of residual cardiovascular disease risk in patients with diabetes
Patel, K. V., & Vaduganathan, M. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000762 · Cited by 4
Raghavan, S., Ho, Y.-L. A., Vassy, J. L., Posner, D. C., Honerlaw, J. P., Costa, L., Phillips, L. S., GAGNON, D. R., Wilson, P. W. F., & Cho, K. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006528 · Cited by 4
Understanding the quality of diabetes care in Japan: a systematic review of the literature
Mitri, J., Sugiyama, T., Tanaka, H., Ohsugi, M., & Gabbay, R. A. (2021) · Diabetology International · doi:10.1007/s13340-021-00497-3 · Cited by 4
“The quality of diabetes care over the last decade has improved but remains suboptimal [1].”
BackgroundHarding, J. L., Benoit, S. R., HORA, I. A., Sridharan, L., Ali, M. K., Jagannathan, R., Patzer, R. E., & Narayan, K. M. V. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002377 · Cited by 4
Self-citationWestall, S., Watmough, S., Narayanan, R. P., Irving, G. J., & Hardy, K. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275980 · Cited by 4
“Several factors have a bearing on the achievement of glycated haemoglobin targets in people with diabetes [22].”
BackgroundSilveira, A. O. S. M., Gomides, M. D. A., & Sadoyama, G. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000541 · Cited by 10
“A North American study with 10 years of followup has shown that almost 50% of the individuals with DM do not reach and maintain the target HbA1c level of < 7% (22).”
BackgroundMcDaniel, C. C., Lo‐Ciganic, W., Garza, K. B., Kavookjian, J., Fox, B. I., & Chou, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1158454 · Cited by 4
“This estimate is similar to other study findings from 1998 to 2018 (10, 11, 29).”
ResultZhang, Y. C., Wei, F., Han, W., Wei, Z. G., Wang, H. L., Wang, M., Zhang, H. H., Zhang, Y. W., & Xu, X. D. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0437-6 · Cited by 4
Position statement of the SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC
Huelgas, R. G., Peralta, F. G., Fernández, L. C., Galve, E., Casanueva, F. F., Puig‐Domingo, M., Bravo, J. J. M., Beltrán, D. O., Muñoz, J. E., Torre, E. L. M., et al. (2015) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2015.09.004 · Cited by 5
Current status of treatment of type 2 diabetes mellitus in Ningbo, China
Yang, T., Zheng, R., Chen, Q., & Mao, Y. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22717 · Cited by 4
Cho, S. K., & Park, K. (2019) · Journal of Nutrition and Health · doi:10.4163/jnh.2019.52.2.206 · Cited by 4
Bala, C. G., Rusu, A., Moise, M., & Román, G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0020 · Cited by 4
“However, observational studies in various groups of patients with T2D reported that attaining the HbA1c target remained unsatisfactory [4-7], although an improvement in the percentage of patients at target from 1999 through 2010 was shown in one study [8].”
BackgroundTanaka, M., Yamamoto, T., Kuribayashi, N., OKUGUCHI, F., Isotani, H., Iwamoto, M., Sugimoto, H., Nakagawa, O., Suzuki, D., Abe, K., et al. (2019) · Diabetology International · doi:10.1007/s13340-019-00413-w · Cited by 4
Turégano-Yedro, M., Cinza‐Sanjurjo, S., Cubelos-Fernández, N., Segura‐Fragoso, A., Sánchez-Sánchez, B., Sánchez-Rodríguez, R., Micó-Pérez, R. M., Velilla-Zancada, S. M., Núñez-Villén, A., Llisterri-Caro, J. L., et al. (2019) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2019.10.008 · Cited by 4
Raghavan, S., Warsavage, T. J., Liu, W. G., Raffle, K., Josey, K., Saxon, D. R., Phillips, L. S., Caplan, L., & Reusch, J. E. B. (2022) · Diabetes Care · doi:10.2337/dc21-2492 · Cited by 6
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-2 · Cited by 6
Kiburg, K., Galligan, A., Sundararajan, V., & MacIsaac, R. J. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108221 · Cited by 5
Kuo, S., Yang, C.-T., Herman, W. H., Lisabeth, L. D., & Ye, W. (2022) · Diabetes Care · doi:10.2337/dc21-2283 · Cited by 5
Endocrinology research—reflecting on the past decade and looking to the next
Herold, K. C., Majzoub, J. A., Melmed, S. K., Pendergrass, M., & Schlumberger, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.164 · Cited by 4
Graciani, A., Rodríguez‐Artalejo, F., Vidal, B. N., & Banegas, J. R. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.07.018 · Cited by 4
Das, B., Sheikh, A., Ahmed, B., & Islam, N. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.5.3901 · Cited by 6
Miranda, J. J., Lazo‐Porras, M., Bernabé‐Ortiz, A., Pesantes, M. A., Diez‐Canseco, F., Cornejo, S. D. P., & Trujillo, A. J. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14824.3 · Cited by 9
mHealth Technologies in Pre-Diabetes and Diabetes Care
Brooke, M. J., & Rege, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00016-8 · Cited by 4
Arrelias, C. C. A., Bellissimo‐Rodrigues, F., de Lima, L. C. L., Rodrigues, F. F. L., Teixeira, C. R. D. S., & Zanetti, M. L. (2018) · Revista gaúcha de enfermagem · doi:10.1590/1983-1447.2017.03.66012 · Cited by 4
Edelman, S. V. (2017) · Clinical Diabetes · doi:10.2337/cd17-0090 · Cited by 5
“0%, and this percentage has not changed over the past decade (1).”
BackgroundEsposito, K., Maiorino, M. I., Bellastella, G., & Giugliano, D. (2014) · Diabetes Care · doi:10.2337/dc13-2511 · Cited by 4
Community Health Workers: A Missing Piece of the Puzzle for Complex Patients With Diabetes?
Garcia, M. E., & Grant, R. W. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3320-8 · Cited by 5
“Achieving evidence-based standards of care for patients with diabetes remains an unsolved challenge, with nearly onehalf of adults with type 2 diabetes not meeting all evidencebased recommendations for diabetes care.(6) Furthermore, an increasing comorbidity burden and the aging of the primary”
BackgroundEpidemiology of Type 2 Diabetes
Ronald, C. W., & Tong, P. C. Y. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch4 · Cited by 8
National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000–2022
Tang, S., Wang, Y., Zhou, X., & Zhang, P. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112154 · Cited by 4
Specialty Group Medical Visits for Patients With Diabetes
Ganetsky, V. S., Brenner, J. C., & Kaufman, S. T. (2017) · Clinical Diabetes · doi:10.2337/cd15-0062 · Cited by 3
“Despite advances in diabetes care through the years, 30–50% of patients do not meet their glycemic, blood pressure, or lipid targets (6).”
BackgroundWinberg, D., Tang, T., Ramsey, Z., Bazzano, A. N., Nauman, E., Li, J., Lin, Y., & Shi, L. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01694-y · Cited by 3
“…despite the availability of prescription drugs proven to regulate blood glucose levels and decrease the risk of complications, it is estimated that anywhere from 30 to 90% of people living with T2DM (PLWD) are not reaching their glycemic goals owing to non-adherence to medication treatments [3, 4].”
Ranasinghe, P. D., Galappatthy, P., Constantine, G. R., Jayawardena, R., Weeratunge, H. D., Premakumara, S., & Katulanda, P. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103357 · Cited by 3
Hayashino, Y., & Ishii, H. (2015) · Diabetology International · doi:10.1007/s13340-015-0216-0 · Cited by 3
“0 % [3, 4], despite the variety of effective treatments available.”
Older Adults Reporting More Diabetes Mellitus Care Have Greater 9‐Year Survival
Han, B. H., Blaum, C. S., Ferris, R. E., Min, L. C., & Lee, P. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13839 · Cited by 3
Gil, A. M. H., Robles, J. P., Repiso, P. S., Maldonado, J. L. M., Garzón, G., & de Miguel, Á. G. (2017) · Atención Primaria · doi:10.1016/j.aprim.2017.04.002 · Cited by 4
Improving Outcomes of People With Diabetes Through Overcoming Therapeutic Inertia
Khunti, K., & Triplitt, C. L. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0067 · Cited by 3
“Only about 50% of patients with diabetes are reaching evidence-based glycemic goals (1), and fewer than 20% of patients have A1C, blood pressure, and LDL cholesterol levels all at goal (2).”
BackgroundLee, E. J., Jeong, I. S., Kim, I. J., Cho, Y. H., & Kim, Y. J. (2021) · International Journal of Nursing Practice · doi:10.1111/ijn.13012 · Cited by 4
Barreto, J., Campos‐Staffico, A. M., Nadruz, W., Quinaglia, T., & Sposito, A. C. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1243530 · Cited by 4
“SGLT2i could enhance the effects of concomitant antihypertensive drugs, thus improving compliance with blood pressure goals and reducing the incidence of adverse outcomes (20, 22).”
Weng, J., Tao, Y., Xu, Z., Zhou, S., Xiao, D., Zhu, Z., Zheng, R., Yang, Y., & Chen, Y. (2024) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12620 · Cited by 3
Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes
Pratley, R. E., & Cersósimo, E. (2017) · Clinical Diabetes · doi:10.2337/cd16-0063 · Cited by 3
Academic and Government Partnerships to Address Diabetes in the USA: a Narrative Review
Yi, S. S., Chamany, S., & Thorpe, L. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0895-y · Cited by 3
Pasqua, M., Hu, X. W., Tardio, V., & Tsoukas, M. A. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.07.002 · Cited by 4
Mosley-Johnson, E., Walker, R. J., Hawks, L. C., Walker, S. L., Mendez, C. E., Campbell, J. A., & Egede, L. E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060263 · Cited by 3
Mardon, R. E., Campione, J. R., Nooney, J. G., Merrill, L. S., Johnson, M. C., Marker, D. A., Jenkins, F., Saydah, S., Rolka, D. B., Zhang, X., et al. (2022) · Population Health Metrics · doi:10.1186/s12963-022-00298-z · Cited by 3
“the ability of public health agencies to monitor diabetes prevention and management at the state level [1].”
BackgroundSelf-citationAkale, M., Tadesse, T., & Arega, B. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s441764 · Cited by 3
“15 but lower than many other studies conducted in Tikur Anbesa Hospital (73.8%), 11 70.8% in Northeast Ethiopia, 16 Saudi Arabia (74.9%), 17 and, Uganda (73.52%).”
ResultInfluentialRepas, T. B. (2014) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2014.085 · Cited by 5
Graciani, A., Rodríguez‐Artalejo, F., Vidal, B. N., & Banegas, J. R. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.07.018 · Cited by 3
“* All of United States data are from Ali et al.4 Auxiliadora Graciani,a,b,* Fernando Rodrı́guez-Artalejo,a,b Beatriz Navarro-Vidal,a and José R. Banegasa,b aDepartamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Autónoma de Madrid/IdiPAZ, Madrid, Spain bCIBER en Epidemiologı́a y Salu…”
BackgroundMethodResultInfluentialChoosing the Best Oral Diabetic Agents in T2 Diabetes Mellitus-Physicians Challenge
Mohanty, B. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000797 · Cited by 3
Tarighat‐Esfanjani, A., Fallahnejad, H., Omidi, H., Jafarabadi, M. A., Abbasi, M. M., & Khorram, S. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.74365 · Cited by 3
Nouraei, H., Leiter, L. A., Tan, M., Langer, A., Teoh, H., CHENG, A. Y. Y., Wald, R., Connelly, K. A., Goodman, S. G., & Yan, A. T.-K. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.02.003 · Cited by 4
López-Cobo, I., Rodríguez-Latre, L., Cunillera, O., Ruiz, I., Copetti, S., Albareda, M., & Vila, L. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110014 · Cited by 3
Diabetes care in South Africa: A tale of two sectors
Landau, S., & May, W. (2013) · South African Medical Journal · doi:10.7196/samj.7010 · Cited by 3
Arguello, V., & Freeby, M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-2121 · Cited by 4
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.